Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5982482 | 0.98 | MEN1 (0.35) | MEN1CYP1A2KMT2ALMNA | |
| SCHEMBL22806927 | 0.90 | CYP1A2 (0.37) | MEN1CYP1A2KMT2ALMNA | |
| SCHEMBL3706004 | 0.86 | MEN1 (0.35) | MEN1CYP1A2KMT2A | |
| SCHEMBL5981608 | 0.79 | — | — | |
| SCHEMBL8849042 | 0.75 | LMNA (0.47) | LMNA | |
| SCHEMBL3709519 | 0.72 | THRB (0.32) | LMNA | |
| SCHEMBL8849027 | 0.72 | THRB (0.35) | LMNA | |
| SCHEMBL27780798 | 0.68 | LMNA (0.32) | MEN1CYP1A2KMT2ALMNA | |
| SCHEMBL27622590 | 0.68 | — | — | |
| SCHEMBL8849111 | 0.66 | THRB (0.38) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160159833-A1 | HYDROXYMETHYL-CARBOXAMIDO-SUBSTITUTED SILANE AND ITS USE FOR CURABLE, SILANE-TERMINATED POLYMERS | SIKA TECHNOLOGY AG (CH) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159833-A1 | HYDROXYMETHYL-CARBOXAMIDO-SUBSTITUTED SILANE AND ITS USE FOR CURABLE, SILANE-TERMINATED POLYMERS | BHMT2, CARM1, EHMT1 | MEN1 1136/4885CYP1A2 2247/4885KMT2A 337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.